UBS Group’s Aterian ATER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15K Sell
5,499
-498
-8% -$326 ﹤0.01% 9133
2025
Q4
$4.17K Buy
5,997
+660
+12% +$577 ﹤0.01% 8879
2025
Q3
$5.6K Buy
5,337
+1,316
+33% +$1.54K ﹤0.01% 8849
2025
Q2
$6.67K Sell
4,021
-73
-2% -$124 ﹤0.01% 9072
2025
Q1
$8.6K Buy
4,094
+3,467
+553% +$7.72K ﹤0.01% 8743
2024
Q4
$1.5K Sell
627
-814
-56% -$2.16K ﹤0.01% 9215
2024
Q3
$4.15K Buy
1,441
+1,354
+1,556% +$4.05K ﹤0.01% 8178
2024
Q2
$244 Hold
87
﹤0.01% 9037
2024
Q1
$240 Sell
87
-204
-70% -$869 ﹤0.01% 8695
2023
Q4
$1.21K Sell
291
-1,561
-84% -$6.02K ﹤0.01% 8373
2023
Q3
$7.26K Buy
1,852
+297
+19% +$1.54K ﹤0.01% 7243
2023
Q2
$8.58K Sell
1,555
-3,415
-69% -$26.6K ﹤0.01% 7226
2023
Q1
$51.3K Sell
4,970
-10
-0.2% -$134 ﹤0.01% 6431
2022
Q4
$46K Buy
4,980
+3,573
+254% +$44.8K ﹤0.01% 6848
2022
Q3
$21K Buy
1,407
+150
+12% +$4.37K ﹤0.01% 7313
2022
Q2
$32K Sell
1,257
-538
-30% -$23.8K ﹤0.01% 6322
2022
Q1
$52K Sell
1,795
-3,305
-65% -$121K ﹤0.01% 6453
2021
Q4
$252K Buy
5,100
+4,495
+743% +$333K ﹤0.01% 5494
2021
Q3
$79K Sell
605
-23
-4% -$2.55K ﹤0.01% 5994
2021
Q2
$110K Buy
628
+246
+64% +$57.5K ﹤0.01% 5803
2021
Q1
$135K Buy
+382
New +$147K ﹤0.01% 5728
2020
Q4
Sell
-156
Closed -$15K 8368
2020
Q3
$15K Buy
156
+135
+643% +$11.9K ﹤0.01% 6506
2020
Q2
$1K Sell
21
-49
-70% -$2.37K ﹤0.01% 7735
2020
Q1
$1K Sell
70
-82
-54% -$4.03K ﹤0.01% 7729
2019
Q4
$11K Buy
152
+6
+4% +$430 ﹤0.01% 7225
2019
Q3
$14K Buy
146
+15
+11% +$1.35K ﹤0.01% 6938
2019
Q2
$13K Buy
+131
New +$11.9K ﹤0.01% 6884

Other funds holding ATER

UBS Group's ATER Position: Q1 2026 in Review

UBS Group reduced its Aterian (ATER) stake by 8.3% in Q1 2026, selling an estimated $326 and leaving 5,499 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #9133.

UBS Group first reported a position in ATER in Q2 2019 and has held it in 27 quarters since. The position peaked at $252K in Q4 2021. 26 funds tracked by Wall St. Rank hold ATER as of Q1 2026.

  • UBS Group held 5,499 shares of Aterian worth $3.15K as of Q1 2026.
  • UBS Group sold 498 Aterian shares in Q1 2026, an estimated $326.
  • Aterian made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9133 holding.
  • UBS Group first reported a position in Aterian in Q2 2019 and has held it in 27 quarters since.
  • UBS Group's Aterian position peaked at $252K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Aterian as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.